Keyphrases
Interferon-α (IFN-α)
100%
Type I Diabetes
100%
Non-obese Diabetic Mice
100%
Interleukin-10
42%
Interleukin-4 (IL-4)
42%
Type 1 Diabetes Mellitus (T1DM)
42%
Adoptive Transfer
28%
Splenocytes
28%
Mitogen
14%
T Cells
14%
Diabetes
14%
Inflammatory Cytokines
14%
Insulin
14%
Type I Interferon
14%
Cell Population
14%
Experimental Autoimmune
14%
Autoimmune
14%
Induced Production
14%
Protective Effect
14%
Effective Treatment
14%
Disease Pattern
14%
Antigen-specific
14%
High-risk Population
14%
Concanavalin A (Con A)
14%
Ionomycin
14%
Cytokine Secretion
14%
Spleen Cells
14%
Esters
14%
Pancreatic β-cells
14%
Splenic Cells
14%
Chronic Relapsing Experimental Autoimmune Encephalomyelitis
14%
Chronic Disorders
14%
Human Autoimmune Diseases
14%
Myristic Acid
14%
Vulnerable Period
14%
Islet Inflammation
14%
Diabetes Type 1
14%
Medicine and Dentistry
Interferon
100%
Insulin Dependent Diabetes Mellitus
100%
Ob/Ob Mouse
100%
Interleukin 10
37%
Interleukin 4
37%
Adoptive Transfer
25%
Disease
12%
Diabetes
12%
T Cell
12%
Antigen Specificity
12%
Secretion (Process)
12%
Cell Population
12%
Diabetes Mellitus
12%
Inflammatory Cytokine
12%
Cytokine Release
12%
Beta Cell
12%
Mitogenic Agent
12%
Autoimmune Disease
12%
High-Risk Population
12%
Spleen Cell
12%
Concanavalin A
12%
Experimental Autoimmune Encephalomyelitis
12%
Ionomycin
12%
Insulitis
12%
Chronic Disorder
12%
Myristic Acid
12%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Dependent Diabetes Mellitus
100%
Interferon
100%
Nonobese Diabetic Mouse
100%
Interleukin 10
37%
Interleukin 4
37%
Disease
25%
Autoimmune Disease
12%
Inflammation
12%
Diabetes Mellitus
12%
Cytokine
12%
Mitogenic Agent
12%
Concanavalin A
12%
Ionomycin
12%
Experimental Autoimmune Encephalomyelitis
12%
Myristic Acid
12%
Insulitis
12%
Immunology and Microbiology
interferon
100%
Nonobese Diabetic Mouse
100%
Splenocyte
50%
Interleukin 4
37%
Interleukin 10
37%
Diabetes Mellitus Type 1
25%
Mitogen
12%
T Cell
12%
Proinflammatory Cytokine
12%
Antigen Specificity
12%
Secretion (Process)
12%
Cell Population
12%
Autoimmune Disease
12%
Cytokine Release
12%
Concanavalin A
12%
Population Risk
12%
Experimental Autoimmune Encephalomyelitis
12%